CYTOMED THERAPEUTICS LTD (GDTC) Stock Analyst Ratings

USA • Nasdaq • NASDAQ:GDTC • SGXZ17669631

0.85 USD
-0.01 (-1.16%)
At close: Feb 3, 2026
0.86 USD
+0.01 (+1.18%)
After Hours: 2/3/2026, 8:20:32 PM
Buy % Consensus

83

ChartMill assigns a Buy % Consensus number of 83% to GDTC. The Buy consensus is the weighted average rating of the current analysts ratings.

  • GDTC was analyzed by 7 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about GDTC.
  • In the previous month the buy percentage consensus was at a similar level.
  • GDTC was analyzed by 7 analysts. More opinions would make the average more meaningful.
GDTC Historical Analyst RatingsGDTC Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -23 -21 -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6
GDTC Current Analyst RatingGDTC Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0 0 0 0 0
Up and Down Grades
Date Firm Action Rating
2024-10-10 Benchmark Reiterate Speculative Buy -> Speculative Buy
2024-06-11 Benchmark Reiterate Speculative Buy -> Speculative Buy
2023-12-04 Benchmark Reiterate Speculative Buy -> Speculative Buy
2023-07-21 Benchmark Initiate Speculative Buy

CYTOMED THERAPEUTICS LTD / GDTC FAQ

Can you provide the consensus rating for CYTOMED THERAPEUTICS LTD stock?

The consensus rating for CYTOMED THERAPEUTICS LTD (GDTC) is 82.8571 / 100 . This indicates that analysts generally have a positive outlook on the stock.


How many analysts cover CYTOMED THERAPEUTICS LTD (GDTC) stock?

The number of analysts covering CYTOMED THERAPEUTICS LTD (GDTC) is 7.